Abstract:In this study, we found that the absence of chromatin remodelling complex (ARID1A) result in increased the density of blood vessels, delayed neurogenesis and decreased gliogenesis. The loss of endothelial ARID1A leads to a persistent decrease in astrocytes after birth. Mechanistically, the deletion of ARID1A in endothelial cells causes a significant increase in H3k27ac and an increase in the secretion of maternal protein 2 (MATN2). In addition, an increase in endothelial cell‐driven MATN2 alters the Akt/SMAD4 signalling pathway through its interaction with the neural progenitor cells (NPCs) receptor EGFR, leading to the decrease of SMAD4. As a transcriptional activator, SMAD complex mediates the expression of downstream targets, thereby promoting neurogenesis and inhibiting gliogenesis. Taken together, these results suggest that ARID1A tightly controls neurogenesis and gliogenesis by regulating the activity of the AKT‐SMAD signalling pathway. The vascular system and the neural system processes occur simultaneously, the interaction among them is fundamental to the normal development of the central nervous system. Arid1a (AT‐rich interaction domain 1A), which encodes an epigenetic subunit of the SWI/SNF chromatin‐remodelling complex, is associated with promoter‐mediated gene regulation and histone modification. However, the molecular mechanism of the interaction between cerebrovascular and neural progenitor cells (NPCs) remains unclear. To generate Arid1acKO‐Tie2 mice, Arid1afl/fl mice were hybridized with Tie2‐Cre mice. The Angiogenesis, neurogenesis and gliogenesis were studied by immunofluorescence staining and Western blotting. RNA‐seq, RT‐PCR, Western blotting, CO‐IP and rescue experiments were performed to dissect the molecular mechanisms of Arid1a regulates fate determination of NPCs. We found that the absence of Arid1a results in increased the density of blood vessels, delayed neurogenesis and decreased gliogenesis, even after birth. Mechanistically, the deletion of Arid1a in endothelial cells causes a significant increase in H3k27ac and the secretion of maternal protein 2 (MATN2). In addition, matn2 alters the AKT/SMAD4 signalling pathway through its interaction with the NPCs receptor EGFR, leading to the decrease of SMAD4. SMAD complex further mediates the expression of downstream targets, thereby promoting neurogenesis and inhibiting gliogenesis. This study suggests that endothelial Arid1a tightly controls fate determination of NPCs by regulating the AKT‐SMAD signalling pathway.

De Novo ARID1B Mutations Cause Growth Delay Associated with Aberrant Wnt/β-Catenin Signaling.

De Novo <i>ARID1B</i> mutations cause growth delay associated with aberrant Wnt/-catenin signaling

Abnormal chromatin remodeling caused by ARID1A deletion leads to malformation of the dentate gyrus

Association between ARID2 and RAS-MAPK pathway in intellectual disability and short stature

Arid1a regulates neural stem/progenitor cell proliferation and differentiation during cortical development

FGD1 Variant Associated with Aarskog–Scott Syndrome

Mutations in ARID2 are associated with intellectual disabilities

KAT6B Genetic Variant Identified in a Short Stature Chinese Infant: A Report of Physical Growth in Clinical Spectrum of KAT6B-Related Disorders

Arid1b haploinsufficiency in pyramidal neurons causes cellular and circuit changes in neocortex but is not sufficient to produce behavioral or seizure phenotypes

Two Loss‐of‐function ANKRD11 Variants in Chinese Patients with Short Stature and a Possible Molecular Pathway

Inhibition of Beta-Catenin Signaling Causes Defects in Postnatal Cartilage Development

Knockdown of Kmt2d leads to growth impairment by activating the Akt/β-catenin signaling pathway

ARID1B maintains mesenchymal stem cell quiescence via inhibition of BCL11B-mediated non-canonical Activin signaling

Specific deletion of Axin1 leads to activation of β-catenin/BMP signaling resulting in fibular hemimelia phenotype in mice

ARID1A-BAF coordinates ZIC2 genomic occupancy for epithelial-to-mesenchymal transition in cranial neural crest specification

Arid1a Loss Enhances Disease Progression in a Murine Model of Osteosarcoma

Insights into the ANKRD11 variants and short-stature phenotype through literature review and ClinVar database search

Endothelial Arid1a deletion disrupts the balance among angiogenesis, neurogenesis and gliogenesis in the developing brain

De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth

Inhibition of Axin1 in osteoblast precursor cells leads to defects in postnatal bone growth through suppressing osteoclast formation

ARID5B influences B-cell development and function in mouse